Circulating IGF System and Treatment Outcome in Epithelial Ovarian Cancer

Endocrine-Related Cancer - United Kingdom
doi 10.1530/erc-13-0274
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

Peritoneal Tumor Spread in Serous Ovarian Cancer-Epithelial Mesenchymal Status and Outcome

Oncotarget
Oncology
2015English

Circulating Sex Steroids During Pregnancy and Maternal Risk of Non-Epithelial Ovarian Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2010English

Perioperative Morbidity and Outcome of Secondary Cytoreduction for Recurrent Epithelial Ovarian Cancer

European Journal of Surgical Oncology
MedicineOncologySurgery
2010English

NuMA Overexpression in Epithelial Ovarian Cancer

PLoS ONE
Multidisciplinary
2012English

Menstrual Pain and Epithelial Ovarian Cancer Risk

Cancer Causes and Control
Cancer ResearchOncology
2014English

Circulating Human Mammary Epithelial Antigens in Breast Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Circulating Cell-Free DNA and Circulating Tumor Cells, the “Liquid Biopsies” in Ovarian Cancer

Journal of Ovarian Research
GynecologyOncologyObstetrics
2017English

OC08.07: Ultrasound-Based Score for Predicting Debulking Surgery Outcome in IIB-IV Stage Epithelial Ovarian Cancer

Ultrasound in Obstetrics and Gynecology
Nuclear MedicineRadiologyUltrasound TechnologyGynecologyReproductive MedicineRadiologicalImagingObstetricsMedicine
2018English

Circulating Biomarkers for Detection of Ovarian Cancer and Predicting Cancer Outcomes

British Journal of Cancer
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy